Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Voyager Therapeutics (VYGR) Leases: 2019-2025

Historic Leases for Voyager Therapeutics (VYGR) over the last 7 years, with Sep 2025 value amounting to $29.7 million.

  • Voyager Therapeutics' Leases fell 13.85% to $29.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.7 million, marking a year-over-year decrease of 13.85%. This contributed to the annual value of $33.3 million for FY2024, which is 146.85% up from last year.
  • As of Q3 2025, Voyager Therapeutics' Leases stood at $29.7 million, which was down 3.98% from $31.0 million recorded in Q2 2025.
  • In the past 5 years, Voyager Therapeutics' Leases registered a high of $39.2 million during Q1 2024, and its lowest value of $13.5 million during Q4 2023.
  • Its 3-year average for Leases is $26.6 million, with a median of $31.0 million in 2025.
  • Its Leases has fluctuated over the past 5 years, first slumped by 53.72% in 2022, then spiked by 161.08% in 2024.
  • Over the past 5 years, Voyager Therapeutics' Leases (Quarterly) stood at $33.5 million in 2021, then crashed by 53.72% to $15.5 million in 2022, then decreased by 12.75% to $13.5 million in 2023, then spiked by 146.85% to $33.3 million in 2024, then fell by 13.85% to $29.7 million in 2025.
  • Its Leases stands at $29.7 million for Q3 2025, versus $31.0 million for Q2 2025 and $32.1 million for Q1 2025.